Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study

Journal of Diabetes and its Complications

Volumn 21, Issue 3, 2007, Pages 172-180

  Romero, Pedro ^a   Baget, Marc ^a   Mendez, Isabel ^a   Fernández, Juan ^a   Salvat, Mercè ^a   Martinez, Inmaculada ^a  

^a Institut Català de la Retina   (Spain)

Author keywords

Diabetic epidemiology; Diabetic macular edema; Diabetic nephropathy; Diabetic retinopathy; Microalbuminuria; Optical coherence tomography

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; VISUAL ACUITY;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; REGISTRIES; RENAL CIRCULATION; SPAIN; VISUAL ACUITY;

EID: 34248147185     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.07.008     Document Type: Article

References (39)

1. Aiello L.P., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris III F.L., and Klein R. Diabetic retinopathy. Diabetes Care 2 (1998) 143-156
2. Aldington S.J., Kohner E.M., Meuer S., Klein R., and Sjolie A.K. Methodology for retinal photography and assessment of diabetic retinopathy. The EURODIAB IDDM complications study. Diabetologia 38 (1995) 437-444
3. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1201
4. American Diabetes Association. Clinical practice recommendations. Diabetes Care 25 Suppl 1 (2002) S1-S147
5. Bresnick G.H. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 90 (1983) 1301-1317
6. Castell C., Tresserras R., Lloveras G., Goday A., Serra J., and Salleras L. Prevalence of diabetes in Catalonia, an OGTT-based population study. Diabetes Research and Clinical Practice 43 (1999) 33-40
7. Consell Assesor sobre Diabetes a Catalunya. Registre de diabetes tipus 1 de Catalunya, 1995-2002. Butlleti Epidemiològic de Catalunya vol. XXIII (4) (2002), Departament de Sanitat i Seguretat Social, Barcelona
8. Cunha-Vaz J. Diabetic macular oedema. European Journal of Ophthalmology 8 (1998) 127-130
9. ETDRS. Detection of diabetic macular edema study no. 5. Ophthalmology 96 (1989) 746-751
10. European Diabetes Policy Group. A desktop guide to type I (insulin-dependent) diabetes mellitus, 1998-1999. Guidelines for diabetes care. Diabetic Medicine 16 (1999) 253-266
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). Journal of the American Medical Association 285 (2001) 2486-2497
12. Ferris III F.L., Chew E.Y., and Hoogwerf B.J. Serum lipids and diabetic retinopathy: Early Treatment of Diabetic Retinopathy Study Research Group. Diabetes Care 19 (1996) 1291-1293
13. Fine B.S., and Brucker A.J. Macular oedema and cystoid macular oedema. American Journal of Ophthalmology 92 (1981) 466-481
14. E-(carboxymethyl-lysine) ELISA. Diabetes Care 26 (2003) 2609-2615
15. Gass J.D.M., Anderson D.R., and Davis E.B. A clinical, fluoresceinic angiographic, and electron microscopic correlationship of cystoid macular oedema. American Journal of Ophthalmology 100 (1985) 82-86
16. Geiss L., Engelgau M., Fraizer E., and Tierney E. Diabetes surveillance, 1997 (1997), Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA
17. Hee M.R., Puliafito C.A., Duker J.S., Reichel E., Coker J.G., Wilkins J.R., Schuman J.S., Swanson E.A., and Fujimoto F.G. Topography of diabetic macular oedema with optical coherence tomography. Ophthalmology 105 (1998) 360-370
18. Kang S.W., Park C.Y., and Ham D.I. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. American Journal of Ophthalmology 137 (2004) 313-322
19. Klein B.E.K., Klein R., and Moss S.E. Is serum cholesterol associated with progression of diabetic retinopathy or macular oedema in persons with younger-onset diabetes of long duration?. American Journal of Ophthalmology 128 (1999) 652-654
20. Klein B.E.K., Klein R., Moss S.E., and Palta M. A cohort study of the relationship of diabetic retinopathy to blood pressure. Archives of Ophthalmology 113 (1995) 601-606
21. Klein R., Klein B.E.K., Moss S.E., and Cruickshanks K.J. The Wisconsin epidemiologic study of diabetic retinopathy: XV. The long term incidence of macular edema. Ophthalmology 102 (1995) 7-16
22. Klein R., Klein B.E.K., Moss S.E., and Cruickshanks K.J. The 14-year incidence and progression of diabetic retinopathy an associate risk factors in type I diabetes. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XVII. Ophthalmology 105 (1998) 1801-1815
23. Klein R., Marino E.K., Kuller L.H., Polak J.F., Gotdiener J.S., Burke G.L., Hubbard L.D., and Boineau R. The relationship of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the cardiovascular health study. British Journal of Ophthalmology 86 (2002) 84-90
24. Klein R., Moss S.E., and Klein B.E.K. Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy?. Ophthalmology 100 (1993) 1140-1146
25. Klein R., Moss S.E., Klein B.E., Davis M.D., and DeMets D.L. The Wisconsin epidemiologic study of diabetic retinopathy: XI. The incidence of macular edema. Ophthalmology 96 (1989) 1501-1510
26. Klein R., Sharrett A.R., Klein B.E.K., Moss S.E., Folsom A.R., Wong T.Y., Brancati F.L., Hubbard L.D., and for the ARIC Group. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes. The Atherosclerosis Risk in Communities Study. Ophthalmology 109 (2002) 1225-1234
27. Kofoed-Enevoldsen A., Jensen T., Borch-Johnsen K., and Deckert T. Incidence of retinopathy in type I (insulin-dependent) diabetes: Association with clinical nephropathy. Journal of Diabetic Complications 1 (1987) 96-99
28. Kohner E.M., Aldington S.J., Stratton I.M., Manley S.E., Holman R.R., Matthews D.R., Turner R.C., and United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38. British Medical Journal 317 (1998) 703-718
29. Landmesser U., McOwen M.D., Bowen Jr. R.M., and O'Marah T.L. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 111 (2004) 712-715
30. Miljanovic B., Glynn R.J., Nathan D.M., Manson J.E., and Schaumberg D.A. A prospective study of serum lipids and risk of diabetic macular edema in type I diabetes. Diabetes 53 (2004) 2883-2892
31. Moss S.E., Klein R., and Klein B.E. Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology 103 (1996) 1438-1442
32. Otani T., Kishi S., and Maruyana Y. Patterns of diabetic macular edema with optical coherence tomography. American Journal of Ophthalmology 127 (1999) 688-693
33. Romero-Aroca P., Espeso-Sentis O., Sarda-Aure P., and del Castillo-Dejardin D. Relationship between microalbuminuria and diabetic retinopathy in type I diabetes mellitus. Revista Clinica Espanola 200 (2000) 351-354
34. Romero-Aroca P., Salvat-Serra M., Mendez-Marin I., and Martinez-Salcedo I. Is microalbuminuria a risk factor for diabetic retinopathy?. Journal Français D'ophtalmologie 26 7 (2003) 680-684
35. Sjolie A.K., Stephenson J., Aldoington S., Kohner E., Janka H., Stevens L., and Fuller J. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology 104 (1997) 252-260
36. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complication Research Group. Retinopathy and nephropathy in patients with type I diabetes four years after a trial of intensive therapy. New England Journal of Medicine 342 (2000) 381-389
37. The Microalbuminuria Collaborative Study Group. Predictors of the development of microalbuminuria in patients with type I diabetes mellitus: A seven-year prospective study. Diabetic Medicine 16 (1999) 918-925
38. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine 157 (1997) 2413-2442
39. Wilkinson C.P., Ferris F.L., Klein R.E., Lee P.P., Agardh C.D., Davis M., Dills D., Kampic A., Verdaguer J.T., and for the Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110 (2003) 1677-1682